Machine learning-derived gut microbiome signature predicts fatty liver disease in the presence of insulin resistance

[1]  Sumit Singh Chauhan,et al.  A review on genetic algorithm: past, present, and future , 2020, Multim. Tools Appl..

[2]  D. Chicco,et al.  The Matthews Correlation Coefficient (MCC) is More Informative Than Cohen’s Kappa and Brier Score in Binary Classification Assessment , 2021, IEEE Access.

[3]  Jeong Hwan Park,et al.  Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD , 2020, Nature Communications.

[4]  R. Knight,et al.  A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. , 2020, Cell metabolism.

[5]  D. Chicco,et al.  The advantages of the Matthews correlation coefficient (MCC) over F1 score and accuracy in binary classification evaluation , 2020, BMC Genomics.

[6]  G. Dreyfuss,et al.  U1 snRNP regulates cancer cell migration and invasion , 2019, bioRxiv.

[7]  Ping Zhang,et al.  Selection of microbial biomarkers with genetic algorithm and principal component analysis , 2019, BMC Bioinformatics.

[8]  J. Grove,et al.  Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis , 2019, Gut microbes.

[9]  Z. Younossi,et al.  The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis. , 2019, Journal of hepatology.

[10]  Y. Hwang,et al.  Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study , 2019, Obesity.

[11]  Francesco Asnicar,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[12]  F. Piñero,et al.  A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma. , 2019, Annals of hepatology.

[13]  A. Uitterlinden,et al.  Relationship between gut microbiota and circulating metabolites in population-based cohorts , 2019, Nature Communications.

[14]  R. Knight,et al.  A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease , 2019, Nature Communications.

[15]  Yoosoo Chang,et al.  Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study , 2018, Hepatology.

[16]  G. Bergström,et al.  Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1 , 2018, Cell.

[17]  S. Lal,et al.  The Human Gut Microbiome – A Potential Controller of Wellness and Disease , 2018, Front. Microbiol..

[18]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[19]  Shibu Yooseph,et al.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. , 2017, Cell metabolism.

[20]  C. Fox,et al.  Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[21]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[22]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[23]  G. Wong,et al.  Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics , 2016, Front. Microbiol..

[24]  Vladimir Brusic,et al.  An adaptive genetic algorithm for selection of blood-based biomarkers for prediction of Alzheimer's disease progression , 2015, BMC Bioinformatics.

[25]  D. Ciocan,et al.  Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease , 2015, Gut.

[26]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[27]  F. Nassir,et al.  Pathogenesis and Prevention of Hepatic Steatosis. , 2015, Gastroenterology & hepatology.

[28]  M. Okano,et al.  Cohort Study , 2020, Definitions.

[29]  Angela C. Poole,et al.  Human Genetics Shape the Gut Microbiome , 2014, Cell.

[30]  G. Shulman,et al.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 Diabetes , 2014, Hepatology.

[31]  Yoosoo Chang,et al.  Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. , 2013, Journal of hepatology.

[32]  Sarah L. Westcott,et al.  Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform , 2013, Applied and Environmental Microbiology.

[33]  M. J. Saad,et al.  The Role of Gut Microbiota on Insulin Resistance , 2013, Nutrients.

[34]  H. Kim,et al.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  N. Lundbom,et al.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. , 2009, Gastroenterology.

[36]  Max Kuhn,et al.  Building Predictive Models in R Using the caret Package , 2008 .

[37]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[38]  Anna Castiglione,et al.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.

[39]  R. Torella,et al.  The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[40]  Francesco Falciani,et al.  GALGO: an R package for multivariate variable selection using genetic algorithms , 2006, Bioinform..

[41]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[42]  Minoru Iwasaki,et al.  Noninvasive Evaluation of Graft Steatosis in Living Donor Liver Transplantation , 2004, Transplantation.

[43]  G Bodemar,et al.  Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[44]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[45]  A. Houston,et al.  Genetic algorithms and evolution. , 1990, Journal of theoretical biology.

[46]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[47]  D. Shephard.  The 1975 Declaration of Helsinki and consent. , 1976, Canadian Medical Association journal.